Chemoinformaics analysis of DEACETYLMATRICARIN
| Molecular Weight | 262.305 | nRot | 0 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 16 |
| Exact Molecular Weight | 262.121 | nRing | 3 |
| Solubility: LogS | -2.916 | nHRing | 1 |
| Solubility: LogP | 0.853 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 40.2603 |
| nHD | 1 | BPOL | 21.5297 |
| QED | 0.747 |
| Synth | 4.481 |
| Natural Product Likeliness | 1.951 |
| NR-PPAR-gamma | 0.704 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.645 |
| HIA | 0.015 |
| CACO-2 | -4.803 |
| MDCK | 0.0000094 |
| BBB | 0.758 |
| PPB | 0.732646 |
| VDSS | 0.783 |
| FU | 0.135845 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.916 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.897 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.886 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.232 |
| CYP3a4-inh | 0.04 |
| CYP3a4-sub | 0.369 |
| CL | 2.808 |
| T12 | 0.191 |
| hERG | 0.023 |
| Ames | 0.176 |
| ROA | 0.413 |
| SkinSen | 0.188 |
| Carcinogencity | 0.102 |
| EI | 0.023 |
| Respiratory | 0.373 |
| NR-Aromatase | 0.906 |
| Antiviral | Yes |
| Prediction | 0.660698 |